Cullinan Therapeutics

Cullinan Therapeutics is a clinical-stage biotechnology company focused on developing novel, targeted therapies for cancer and autoimmune diseases. They take a modality-agnostic approach, meaning they are not limited to a specific type of treatment and can pursue the best modality to address each target. This has resulted in a diverse pipeline of clinical-stage programs with a variety of targets, mechanisms, and modalities. They are dedicated to creating new standards of care for patients by bringing forward only the most promising therapies and employing robust translational research to fully inform their clinical approach.

Cullinan Therapeutics prioritizes collaboration and has a deep commitment to diversity, equity, and inclusion. Their company culture encourages open communication, respect for all opinions, and a sense of urgency to deliver innovative solutions to patients. They believe in supporting the communities they operate in and give their team the opportunities for mentorship and growth. Cullinan Therapeutics is committed to working towards a future where patient care is personalized, toxicity minimized, and efficacy fully maximized.

Cullinan Therapeutics offers a variety of work-life balance benefits including flexible paid time off, 12 paid holidays plus an end-of-year shutdown, Summer Friday half-days, hybrid/remote work options, parental leave, and company-paid commuter benefits. Additionally, there is an on-site gym, gym and fitness reimbursement for medical plan members, and an employee assistance program (EAP).

Cullinan Therapeutics offers a comprehensive benefits package to its employees, including competitive compensation, 401(k) plan with a 5% match, stock options, and an employee stock purchase plan. They also provide health, dental, and vision insurance, with the company contributing 90% of the premium for health and dental. Additionally, they offer flexible paid time off, 12 paid holidays, a company-funded gym, and a tuition reimbursement program.

Cullinan Therapeutics is a biotechnology company committed to creating new standards of care for patients by discovering and developing innovative, modality-agnostic targeted therapies. They prioritize patient benefit and are driven by a deep understanding of oncology, immunology, and translational medicine, leading to a diverse pipeline of clinical-stage programs aimed at inhibiting key disease drivers or harnessing the immune system to eliminate diseased cells.

Cullinan Therapeutics promotes a collaborative and inclusive culture that emphasizes scientific creativity, patient-centricity, and respect for all opinions. The company encourages open communication and diverse perspectives, fostering a sense of urgency and agility to deliver meaningful therapies to patients. They value teamwork, innovation, and a commitment to improving patient outcomes, creating an environment where employees can learn, grow, and contribute to the company's mission.

Cullinan Therapeutics prioritizes diversity, equity and inclusion as a core value, believing it is essential to their mission of creating new standards of care for patients. They embed DEI principles in every aspect of their operations, including recruitment, hiring, development and advancement. They also aim to advance health equity through inclusive clinical trial recruitment and work to foster an inclusive culture where everyone feels valued. They are committed to regularly reviewing and evolving their DEI practices to ensure a positive and transformative impact for employees, patients and the healthcare industry as a whole.